Drugs / UFT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00190515 | Feb 2003 → Nov 2011 | colorectal neoplasm | Haruhiko Fukuda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UFT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00190515 ↗ |
| Route | Oral | “UFT+LV: UFT 300mg/m2/day and LV 75mg/day, orally for 28days with 7days rest, repeated five times every 5 weeks.” NCT00190515 ↗ |